Sumant Kulkarni joined Canaccord Genuity in May 2017 as a New York-based Managing Director covering Biotechnology stocks. His initial research focus is on biotech companies within the neurology/neuroscience space.

e-Meet Sumant at #Sachs_ELSF

More info @ https://t.co/YXBF2fUYBz pic.twitter.com/NCuvEaElf6

— Sachs Associates (@SachsAssociates) February 2, 2021